From 10 to 12 May 2025, our subsidiary OphtAI, an artificial intelligence solution dedicated to ophthalmological screening, looks forward to seeing you at the Congress of the French Ophthalmology Society (SFO), stand L15B – level 1, at the Palais des Congrès in Paris.
An unmissable event for discovering the latest technological advances that are transforming visual care, at the heart of our responsible innovation mission.
Ever more comprehensive IA screening
Developed by Evolucare and its partners, OphtAI uses expert algorithms to automatically detect a wide range of eye conditions. In 2025, the solution will be enhanced with new clinical indicators, including:
- Naevus / naevi
- Hypertensive retinopathy
- Retinal vein occlusion (CRVO + BRVO)
- Macular hole
- Epithelial membrane detachment
- Cataract
- High myopia
- Retinitis pigmentosa
- Laser photocoagulation scars
- Pigmentary migration
- Alteration of the retinal pigment epithelium
- Normal/abnormal eye (patented technology)
- MIDD
These innovations complement the pathologies already being treated, such as diabetic retinopathy, AMD, DR, drusen and glaucoma.
A new user experience with MyOphtAI
In a context of overburdened healthcare professionals, OphtAI is pushing the boundaries of efficiency with a new offer: MyOphtAI. A simple, no-commitment monthly subscription, including a free one-month trial and unlimited use. The aim is to democratise access to quality AI screening and automate the classification of files.
👉 Zero clicks, zero hassle. File your records automatically..
A strong ecosystem of integrators and partners
Our solution is supported by recognised integrators: Topcon, Optomed, Crystalvue and Umami View, and supported by strategic partners: Oplus, Téo and Area. This technical synergy guarantees optimal interoperability and the effective dissemination of uses in the field.
A stand for testing, exchanging and anticipating
At our stand L15B, you can discover the use cases of OphtAI, talk to our AI experts and test the new features in real conditions. This is an opportunity to (re)discover how our technology reinforces the action of healthcare professionals, with a view to early diagnosis, saving time and combating inequalities in access to ophthalmic care.
Already a strong commitment in 2024
In 2024, OphtAI made a strong impression at the 4th Retina and Diabetes Day, bringing together ophthalmologists and healthcare professionals to discuss the challenges of AI-assisted screening. This event demonstrates our commitment to building a seamless continuum of care, in line with our #Pact4all project.
📅 Come and meet us at stand L15B – level 1 of the Palais des Congrès in Paris, from 10 to 12 May 2025.
🔍 More info on OphtAI : https://www.ophtai.com/
💬 Follow the latest news from OphtAI on LinkedIn